NCT06837025 (CP fascia) is a NA clinical trial of Fascial manipulation in Cerebral Palsy (CP), sponsored by Orton Orthopaedic Hospital.

Who is sponsoring NCT06837025?

NCT06837025 is sponsored by Orton Orthopaedic Hospital.

What drugs are being tested in NCT06837025?

Interventions in NCT06837025: Fascial manipulation.

What condition does NCT06837025 study?

NCT06837025 studies Cerebral Palsy (CP).

Is NCT06837025 still recruiting?

NCT06837025 is currently recruiting now. Last updated 24 February 2025.

Last reviewed 2025-02-24 · How we verify

NCT06837025: CP fascia

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fascial Manipulation in Cerebral Palsy Rehabilitation

Recruiting now NA Last updated 24 February 2025

What this trial tests

NA trial testing Fascial manipulation in Cerebral Palsy (CP) in 20 participants. Currently enrolling.

Timeline

4 October 2024

Primary endpoint
31 December 2027

31 December 2027

Quick facts

Lead sponsor	Orton Orthopaedic Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	20
Start date	4 October 2024
Primary completion	31 December 2027
Estimated completion	31 December 2027
Sites	1 location across Finland

Drugs / interventions tested

Fascial manipulation

Conditions studied

Cerebral Palsy (CP) — all drugs for Cerebral Palsy (CP) →

Sponsor

Orton Orthopaedic Hospital

Who can join

Adults 7 to 14, any sex, with Cerebral Palsy (CP). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to investigate the potential additional benefits of a relatively new physiotherapy method, fascial manipulation, in the rehabilitation of movement difficulties or other problems caused by CP (cerebral palsy). A physiotherapist specialized in fascial manipulation specifically treats the muscle fascia, which plays a central role in the problems associated with CP. Fascial manipulation feels just like a massage but does not hurt. The purpose of the study is to determine how physiotherapeutic rehabilitation methods should be further developed in Finland and elsewhere. Fascial manipulation was originally developed in Italy and is used to treat many musculoskeletal problems. There have been few studies on the effectiveness of fascial manipulation in the context of CP problems. It is important to obtain more research evidence, which is why conducting this study is crucial.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Fascial manipulation

Trials testing the same drug.

NCT03198260 — Observing the Effect of Fascial Manipulation in Athletes With Shin Splits.Tibial Stress Syndrome. · NA · completed

Other recruiting trials for Cerebral Palsy (CP)

Currently open trials in the same condition.

NCT07587476 — Constraint-induced Movement Therapy Combined With Functional Electrical Stimulation in Children With Cerebral Palsy · NA · recruiting
NCT07500896 — Effects of an Intensive Rhythmic Dance Program on Learning Skills in Children With Cerebral Palsy · recruiting
NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
NCT07377201 — Childhood Toxin Perception Survey · recruiting
NCT07311018 — Neuromuscular Electrical Stimulation and Leap Motion-Based Exercises in Cerebral Palsy · NA · recruiting

Other Orton Orthopaedic Hospital trials

Trials by the same sponsor.

NCT05450263 — Preventing Chronicity of Sub-acute Low Back Pain by Altering the Neural Emotional Response to Pain · NA · withdrawn
NCT05641857 — Lumbar Spine on MRI and Low Back Pain in Elite Cross-country Skiers · completed
NCT04719624 — Novel Porous Bioceramic Material as a Bone Substitute · NA · terminated
NCT03904030 — Postoperative Rehabilitation After Knee Arthroplasty: Anti-Gravity Treadmill · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06837025 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Orton Orthopaedic Hospital
Last refreshed: 24 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06837025.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing